Navigation Links
Pill Equals Injection in Preventing Clots After Hip Replacement
Date:9/14/2007

Study found no difference between the two protective treatments

FRIDAY, Sept. 14 (HealthDay News) -- In a head-to-head trial, Swedish researchers found that a pill called dabigatran etexilate (DE) is just as effective as an injected drug, enoxaparin, in reducing the risk of blood clots after total hip replacement surgery.

As reported in this week's issue of The Lancet, the study included almost 3,500 hip replacement patients who received either oral DE at 220 milligrams daily, DE at 150 milligrams daily, or an injection of enoxaparin at 40 milligrams once daily, for 28 to 35 days.

Blood clots or death from all causes occurred in 53 of 880 (6 percent) of patients on 220 milligrams DE, in 75 of 874 (8.6 percent) of patients on 150 milligrams DE, and in 60 of 897 (6.7 percent) of patients in the enoxaparin group.

The researchers found no significant differences in bleeding rates, frequency of coronary events, or increases in liver enzyme concentrations between the three groups of patients.

There were also no differences between the groups in terms of "reducing the risk of total venous thromboembolism, and all-cause mortality after total hip replacement," wrote the researchers from Sahlgrenska University Hospital in Gothenburg.

The study was funded by Boehringer Ingelheim, the company that makes DE.

In an accompanying editorial, Dr. John Norrie of the Centre for Healthcare Randomised Trials at the University of Aberdeen in Scotland, also notes that the study did have methodological flaws, linked to missing data.

More information

The MedlinePlus Medical Encyclopedia has more about blood clots.



-- Robert Preidt



SOURCE: The Lancet, news release, Sept. 13, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Calcium and Protein Equals Strong Bones
2. Good Oral Health Equals Good Health for Your Heart
3. Cement injections linked to osteoporosis
4. Sharing injection equipment spreads Hepatitis C
5. Toxin injections support stroke associated spasticity
6. Injection supports Heart Devices
7. Abstinence From Alcohol With The Help Of An Injection
8. Exubera could mean the end of an insulin injection era for diabetics
9. Unsafe Injections and Unclean Hand hygiene major cause of hospital infections in India
10. Leptin Injections Maintain Loss In Body Weight
11. FDA Approves Novel Creation of Imitrex? Injection for Migraine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is underway. ... ambulance transport experience for the millions of people who require these medical transport ... taxi industry through the use of technology. Now, SmartEMS has put forth an ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer ... they remain in the eye of the beholder, according to experts who offered insights ... American Journal of Managed Care. For the full issue, click here . , ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/26/2016)... ... ... legally blind and certified personal trainer is helping to develop a weight loss fitness plan ... fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
Breaking Medicine Technology: